U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. K & B Company Inc. - 528522 - 09/12/2018
  1. Warning Letters

CLOSEOUT LETTER

K & B Company Inc. MARCS-CMS 528522 —

Delivery Method:
UPS Overnight
Recipient:
Recipient Name
Brent A. Bischoff
Recipient Title
President
K & B Company Inc.
K & B Company Inc.

109 Arnold St.
Gallup, NM 87301
United States

Issuing Office:
Office of Human and Animal Foods-Division IV West

United States

September 12, 2018

WARNING LETTER CLOSE-OUT

VIA UPS overnight

Brent A. Bischoff
President
K & B Company Inc.
109 Arnold St.
Gallup, NM 87301

Dear Mr. Bischoff:

The Food and Drug Administration has completed an evaluation of K & B Company's corrective actions in response to our Warning Letter HAF4W(DEN)-17-09-WL (DR) dated July 5, 2017. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
LaTonya M. Mitchell
District Director, FDA Denver District
Program Division Director
Office of Human and Animal Foods - Division IV West

Back to Top